Indications
Indications
- As a combination therapy with alpha-1-blockers for the treatment and prevention of the progression of benign prostatic hyperplasia by reducing its size, relieving symptoms, improving urination, reducing the risk of acute urinary retention and the need for surgery. A combination of dutasteride and the alpha-1-blocker tamsulosin was mainly studied.
- As a monotherapy for the treatment and prevention of the progression of benign prostatic hyperplasia by reducing its size, relieving symptoms, improving urination, reducing the risk of acute urinary retention and the need for surgery.
Reviews
There are no reviews yet.